# Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

> **NCT01978184** · PHASE2 · COMPLETED · sponsor: **Nathan Bahary, MD** · enrollment: 104 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** abraxane
- **DRUG:** hydroxychloroquine

## Key facts

- **NCT ID:** NCT01978184
- **Lead sponsor:** Nathan Bahary, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2018-02-06
- **Final completion:** 2018-02-28
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978184, "Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01978184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*